Richard Y. Ebright

Richard Y. Ebright is a Clinical Fellow in Oncology at Dana-Farber Cancer Institute, a position held since July 2023, while also serving as a Consultant at Third Rock Ventures since May 2023, focusing on early-stage companies in scientific and operational roles. Previously, Richard Y. Ebright completed an Internal Medicine Residency at Massachusetts General Hospital from June 2021 to July 2023 and was a Fellow at Nextech Invest, conducting scientific due diligence on oncology biotech investments from March 2020 to October 2022. Richard Y. Ebright earned an MD and PhD from Harvard Medical School and Harvard University, respectively, and holds an A.B. magna cum laude in Chemical and Physical Biology from Harvard University. Additional experience includes roles at nference as a Clinical Scientist, at Harvard University under esteemed mentors, and as an Undergraduate Research Assistant at the Broad Institute.